Germany · Delayed Price · Currency is EUR PVA TePla AG Earnings Call Transcripts
Fiscal Year 2026
-
Record Q1 order intake of EUR 121.6 million, with revenue down 6.7% year-over-year due to strategic investments and segment transition. Full-year guidance is confirmed, with strong order momentum in both Material Solutions and Metrology supporting improved profitability ahead.
Fiscal Year 2025
-
2025 saw stable gross margins and strong order momentum despite lower revenue, with significant investments in technology and organizational transformation. 2026 guidance anticipates moderate revenue growth, supported by a robust order backlog and continued expansion in high-growth markets.
-
Q3 revenue fell short due to external customer delays, but order intake and book-to-bill ratios remain strong. Guidance for 2025 was reduced, with gradual recovery and growth expected in 2026, supported by robust demand in Metrology and Material Solutions.
-
The company is executing a strategic transformation, focusing on proactive sales, innovation, and regional expansion. It targets $500 million in sales by 2028, driven by metrology and material solutions, with significant investments in R&D and local presence. Growth is supported by new technologies, M&A, and a scalable business model.
-
Gross margin improved to 33.3% and order intake surged 43% year-over-year, despite an 11.6% sales decline due to project delays. Strategic investments in metrology and R&D are driving future growth, with confidence in meeting year-end guidance at the lower end of the target range.
Fiscal Year 2024
-
2024 saw strong operational and financial results, with EBITDA up 16% and a strategic shift toward higher-margin, less cyclical metrology business. 2025 will be a transition year with stable sales and lower margins due to investments, but growth and margin recovery are expected from 2026 onward.
-
Sales grew 3.7% to €198.3M and EBITDA rose 11% to €32.4M, with strong margins despite a weak semiconductor market. Metrology now accounts for 34% of sales, and strategic investments continue in R&D and infrastructure. Guidance for 2024 remains at the lower end.